Florêncio Rodopiano S, Meira Melaynne S B, Cunha Marcos V da, Camarço Mylena N C R, Castro Eduardo C, Finotti Marta C C F, Oliveira Vinicius A de
Humana Medicina Reprodutiva - Goiania, GO.
Medicine School, Federal University of Goias.
JBRA Assist Reprod. 2018 Mar 1;22(1):8-14. doi: 10.5935/1518-0557.20180005.
To evaluate the predictive efficiency of serum estradiol (E) concentration in the mid-luteal phase regarding chemical, clinical, and ongoing pregnancies, in patients subjected to IVF/ICSI with fresh embryo transfer.
One hundred and forty-three patients undergoing IVF/ICSI met all the inclusion criteria for the present study. Most of the patients used antagonists, final maturation was achieved with recombinant chorionic gonadotrophin (HCG), and embryo transfer took place on days 3 to 5, but mostly on day 4. The luteal phase was supplemented with estradiol valerate 6 mg/day and vaginal micronized progesterone 600 mg/day. There was no exclusion of patients in the embryo transfer group due to age or ovarian reserve. All patients with estradiol and chorionic gonadotrophin (βHCG) dosage on the day of transfer, day 7, were included. We assessed the following variables, initially regarding age: number of eggs collected, formed embryos, embryos transferred, day of transfer, transfer type, estradiol and chorionic gonadotropin. Next, we evaluated these elements at three different ranges of estradiol concentrations (<200 pg/ml, 200-500 pg/ml, and >500 pg/ml), comparing these parameters in pregnant (P) and non-pregnant (NP) patients.
Data analysis by age group in P and NP patients showed significant differences in the mean values of the variables E and βHCG, TD7. Mean serum estradiol levels in P and NP in the three age groups were: <35 years, 835/417 p=0.0006, 35-39 years 833/434 p=0.0118, >39 years, 841/394 p=0.0012. There was also a significant difference in pregnancy rates in the group >500 pg/ml of estradiol concentration (63.4%, p=0.0096). The likelihood of chemical and clinical abortions for the estradiol ranges were: 38.46%, involving the two first ranges versus 15.15% for a concentration >500 pg/ml, p=0.0412 and 5.26% for a concentration >900 pg/ml, p=0.0105. The Pearson correlation coefficient for HCG and estradiol was r=0.5108.
This study showed the prognostic value of E in the mid-luteal phase (TD7) for chemical, clinical, and ongoing pregnancies, and its concentration suggested that there is a moderately positive correlation with βHCG levels.
评估在接受新鲜胚胎移植的体外受精/卵胞浆内单精子注射(IVF/ICSI)患者中,黄体中期血清雌二醇(E)浓度对生化妊娠、临床妊娠及持续妊娠的预测效率。
143例接受IVF/ICSI的患者符合本研究的所有纳入标准。大多数患者使用拮抗剂,采用重组绒毛膜促性腺激素(HCG)实现最终成熟,胚胎移植在第3至5天进行,但大多在第4天。黄体期补充戊酸雌二醇6mg/天和阴道微粒化孕酮600mg/天。胚胎移植组不排除因年龄或卵巢储备因素的患者。纳入所有在移植日(第7天)有雌二醇和绒毛膜促性腺激素(βHCG)剂量数据的患者。我们首先评估以下变量与年龄的关系:取卵数、形成的胚胎数、移植的胚胎数、移植日、移植类型、雌二醇和绒毛膜促性腺激素。接下来,我们在三个不同的雌二醇浓度范围(<200pg/ml、200 - 500pg/ml和>500pg/ml)评估这些因素,比较妊娠(P)和未妊娠(NP)患者的这些参数。
按年龄组对P和NP患者进行数据分析显示,变量E和βHCG、TD7的平均值存在显著差异。三个年龄组中P和NP患者的平均血清雌二醇水平分别为:<35岁,835/417,p = 0.0006;35 - 39岁,833/434,p = 0.0118;>39岁,841/394,p = 0.0012。在雌二醇浓度>500pg/ml的组中,妊娠率也存在显著差异(63.4%,p = 0.0096)。不同雌二醇浓度范围的生化流产和临床流产可能性分别为:前两个范围为38.46%,而浓度>500pg/ml时为15.15%,p = 0.0412;浓度>900pg/ml时为5.26%,p = 0.0105。HCG与雌二醇的Pearson相关系数为r = 0.5108。
本研究显示了黄体中期(TD7)E对生化妊娠、临床妊娠及持续妊娠的预后价值,其浓度与βHCG水平呈中度正相关。